The Presence of Neutrophil Extracellular Traps (NETs) in Brain Tumor Vessels Is Linked to Platelet Aggregates and Podoplanin in the Tumor Microenvironment

<b>Background</b>: Multiple mechanisms might lead to cancer-related hypercoagulability. In brain tumors, podoplanin, via its ability to activate platelets, seems to play a crucial role in developing venous thromboembolism (VTE). Different stimuli (including activated platelets) can trigger the release of prothrombotic neutrophil extracellular traps (NETs) by neutrophils. It remains to be elucidated whether podoplanin-induced platelet aggregates might also impact NET formation and subsequent hypercoagulability and thrombosis. <b>Methods</b>: Patients with glioma were enrolled in this prospective observational cohort study. The primary endpoint was VTE. Immunohistochemical staining of NETs (via citrullinated histone H3 [H3Cit]) and neutrophils (via myeloperoxidase [MPO]) was conducted in glioma specimens and correlated with intravascular platelet clusters (via CD61) and podoplanin. <b>Results</b>: In total, 154 patients were included. H3Cit+ tumor vessels were found in 45/154 cases. H3Cit were significantly associated with increased intravascular platelet clusters (CD61- vs. CD61+ vs. CD61++ vs. CD61+++: 3.7% (1/27) vs. 18.6% (11/59) vs. 39.4% (13/33) vs. 57.1% (20/35), <i>p</i> < 0.001) and podoplanin expression (PDPN- vs. PDPN+: 14.3% (7/49) vs. 36.2% (38/105), <i>p</i> = 0.007) in the tumor tissue. Furthermore, H3Cit+ tumor vessels were significantly associated with tumor-infiltrating MPO+ neutrophils (H3Cit- vs. H3Cit+, median [Q1-Q3]: 6.0 [3.3-12.3] vs. 12.5 [5.9-22.0] cells/mm<sup>2</sup>, <i>p</i> < 0.001) and with D-dimer levels (H3Cit- vs. H3Cit+: 0.53 [0.32-1.10] vs. 0.84 [0.46-2.75] µg/mL, <i>p</i> = 0.034). The VTE risk was not linked to H3Cit+ tumor vessels (<i>p</i> = 0.613, log-rank). <b>Conclusions</b>: H3Cit in tumor vessels was not associated with VTE. However, H3Cit was linked to a local procoagulant phenotype in glioma, thereby potentially contributing to a systemic hypercoagulable state and thrombus formation.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2025-09-27
DOI
https://doi.org/10.3390/cancers17193141
Primary Topic
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Presence of Neutrophil Extracellular Traps (NETs) in Brain Tumor Vessels Is Linked to Platelet Aggregates and Podoplanin in the Tumor Microenvironment

Ingrid Pabinger, Christine Brostjan, Cihan Ay, Thomas Roetzer-Pejrimovsky et al.
Cancers
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
article

The Presence of Neutrophil Extracellular Traps (NETs) in Brain Tumor Vessels Is Linked to Platelet Aggregates and Podoplanin in the Tumor Microenvironment

Ingrid Pabinger, Christine Brostjan, Cihan Ay, Thomas Roetzer-Pejrimovsky, Pegah Mir Seyed Nazari, Johannes A. Hainfellner, Julia Riedl, Matthias Preusser, Maximilian J. Mair, Öykü Özer, Christine Marosi
article en

Abstract

<b>Background</b>: Multiple mechanisms might lead to cancer-related hypercoagulability. In brain tumors, podoplanin, via its ability to activate platelets, seems to play a crucial role in developing venous thromboembolism (VTE). Different stimuli (including activated platelets) can trigger the release of prothrombotic neutrophil extracellular traps (NETs) by neutrophils. It remains to be elucidated whether podoplanin-induced platelet aggregates might also impact NET formation and subsequent hypercoagulability and thrombosis. <b>Methods</b>: Patients with glioma were enrolled in this prospective observational cohort study. The primary endpoint was VTE. Immunohistochemical staining of NETs (via citrullinated histone H3 [H3Cit]) and neutrophils (via myeloperoxidase [MPO]) was conducted in glioma specimens and correlated with intravascular platelet clusters (via CD61) and podoplanin. <b>Results</b>: In total, 154 patients were included. H3Cit+ tumor vessels were found in 45/154 cases. H3Cit were significantly associated with increased intravascular platelet clusters (CD61- vs. CD61+ vs. CD61++ vs. CD61+++: 3.7% (1/27) vs. 18.6% (11/59) vs. 39.4% (13/33) vs. 57.1% (20/35), <i>p</i> < 0.001) and podoplanin expression (PDPN- vs. PDPN+: 14.3% (7/49) vs. 36.2% (38/105), <i>p</i> = 0.007) in the tumor tissue. Furthermore, H3Cit+ tumor vessels were significantly associated with tumor-infiltrating MPO+ neutrophils (H3Cit- vs. H3Cit+, median [Q1-Q3]: 6.0 [3.3-12.3] vs. 12.5 [5.9-22.0] cells/mm<sup>2</sup>, <i>p</i> < 0.001) and with D-dimer levels (H3Cit- vs. H3Cit+: 0.53 [0.32-1.10] vs. 0.84 [0.46-2.75] µg/mL, <i>p</i> = 0.034). The VTE risk was not linked to H3Cit+ tumor vessels (<i>p</i> = 0.613, log-rank). <b>Conclusions</b>: H3Cit in tumor vessels was not associated with VTE. However, H3Cit was linked to a local procoagulant phenotype in glioma, thereby potentially contributing to a systemic hypercoagulable state and thrombus formation.

CancersVol. 17(19)
Medical University of Vienna (AT)
Openalex Percentile: Top 72%
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.